Diagnosis and Treatment of Cushing's Syndrome. Cushing's Syndrome: Current Clinical Problems, Symposium. Padova, October 19-20, 1990

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 1992 Mar 1

PMID 1624684

Affiliations

Soon will be listed here.

References

Marzouk H, Zuyderwijk J, Uitterlinden P, de Jong F, Lamberts S . Suramin prevents ACTH-stimulated corticosterone release by dispersed adrenocortical cells. Endocrinology. 1990; 126(1):666-8. DOI: 10.1210/endo-126-1-666. View

Lamberts S, DE LANGE S, Stefanko S . Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. J Clin Endocrinol Metab. 1982; 54(2):286-91. DOI: 10.1210/jcem-54-2-286. View

Hardy J . Presidential address: XVII Canadian Congress of Neurological Sciences. Cushing's disease: 50 years later. Can J Neurol Sci. 1982; 9(4):375-80. View

Reubi J, Kvols L, Krenning E, Lamberts S . Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 1990; 39(9 Suppl 2):78-81. DOI: 10.1016/0026-0495(90)90217-z. View

Patel Y, Murthy K, Escher E, Banville D, Spiess J, Srikant C . Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism. 1990; 39(9 Suppl 2):63-9. DOI: 10.1016/0026-0495(90)90214-w. View

Invitti C, Pecori Giraldi F, Dubini A, Piolini M, Cavagnini F . Effect of sandostatin on CRF-stimulated secretion of ACTH, beta-lipotropin and beta-endorphin. Horm Metab Res. 1991; 23(5):233-5. DOI: 10.1055/s-2007-1003660. View

Bertagna X, Bertagna C, LAUDAT M, Husson J, Girard F, LUTON J . Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome. J Clin Endocrinol Metab. 1986; 63(3):639-43. DOI: 10.1210/jcem-63-3-639. View

Tyrrell J, Lorenzi M, Gerich J, FORSHAM P . Inhibition by somatostatin of ACTH secretion in Nelson's syndrome. J Clin Endocrinol Metab. 1975; 40(6):1125-7. DOI: 10.1210/jcem-40-6-1125. View

Jara-Albarran A, Bayort J, Caballero A, Eusebio R, Garcia-Peris P, Toledano E . No inhibition of corticotrophin (ACTH)-hypersecretion in adrenal insufficiency by somatostatin. Acta Endocrinol (Copenh). 1980; 95(1):71-4. DOI: 10.1530/acta.0.0950071. View

10.

Lamberts S, Bakker W, Reubi J, Krenning E . Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990; 323(18):1246-9. DOI: 10.1056/NEJM199011013231805. View

11.

Halberg F, SHELINE G . Radiotherapy of pituitary tumors. Endocrinol Metab Clin North Am. 1987; 16(3):667-84. View

12.

BURKE C, Adams C, Esiri M, Morris C, Bevan J . Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?. Clin Endocrinol (Oxf). 1990; 33(4):525-37. DOI: 10.1111/j.1365-2265.1990.tb03890.x. View

13.

Oldfield E, Chrousos G, Schulte H, Schaaf M, McKeever P, KRUDY A . Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med. 1985; 312(2):100-3. DOI: 10.1056/NEJM198501103120207. View

14.

Allolio B, Gunther R, Benker G, REINWEIN D, Winkelmann W, Schulte H . A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease. J Clin Endocrinol Metab. 1990; 71(5):1195-201. DOI: 10.1210/jcem-71-5-1195. View

15.

Lamberts S, Bruining H, Marzouk H, Zuiderwijk J, Uitterlinden P, Blijd J . The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro. J Clin Endocrinol Metab. 1989; 69(4):896-901. DOI: 10.1210/jcem-69-4-896. View

16.

Findling J, Aron D, Tyrrell J, Shinsako J, FITZGERALD P, Norman D . Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome. Ann Intern Med. 1981; 94(5):647-52. DOI: 10.7326/0003-4819-94-5-647. View

17.

Nieman L, Chrousos G, Kellner C, Spitz I, Nisula B, Cutler G . Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 1985; 61(3):536-40. DOI: 10.1210/jcem-61-3-536. View

18.

Ambrosi B, Bochicchio D, FERRARIO R, Colombo P, Faglia G . Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism. J Endocrinol Invest. 1989; 12(1):31-5. DOI: 10.1007/BF03349913. View

19.

Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Olivier L, RACADOT J . Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab. 1988; 66(5):1056-64. DOI: 10.1210/jcem-66-5-1056. View

20.

Lamberts S, Bakker W, Reubi J, Krenning E . Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs. Metabolism. 1990; 39(9 Suppl 2):152-5. DOI: 10.1016/0026-0495(90)90235-5. View